Home / Drug shortages / Promethazine Hydrochloride Injection

Promethazine Hydrochloride Injection — FDA Drug Shortage

Current — Hikma Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Promethazine Hydrochloride Injection (injection) from Hikma Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on 11/21/2023.

Shortage Details

Status
Current
Company
Hikma Pharmaceuticals USA, Inc.
Package NDC
0641-1495-35
Dosage Form
Injection
Presentation
Promethazine Hydrochloride, Injection, 25 mg/1 mL (NDC 0641-1495-35)
Initial Posting
11/21/2023
Revised Date

FDA data resources